Publication | Open Access
Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple‐Masked, Placebo‐Controlled Clinical Trial
32
Citations
17
References
2021
Year
Over an eight-week period, 24 mg daily xanthohumol was safe and well-tolerated by healthy adults.
| Year | Citations | |
|---|---|---|
Page 1
Page 1